Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Data from the largest randomized, controlled trial for the treatment of children hospitalized with severe malaria were used to identify such predictors of a poor outcome from severe malaria. METHODS: African children (<15 years) with severe malaria participated in a randomized comparison of parenteral artesunate and parenteral quinine in 9 African countries. Detailed clinical assessment was performed on admission. Parasite densities were assessed in a reference laboratory. Predictors of death were examined using a multivariate logistic regression model. RESULTS: Twenty indicators of disease severity were assessed, out of which 5 (base deficit, impaired consciousness, convulsions, elevated blood urea, and underlying chronic illness) were associated independently with death. Tachypnea, respiratory distress, deep breathing, shock, prostration, low pH, hyperparasitemia, severe anemia, and jaundice were statistically significant indicators of death in the univariate analysis but not in the multivariate model. Age, glucose levels, axillary temperature, parasite density, heart rate, blood pressure, and blackwater fever were not related to death in univariate models. CONCLUSIONS: Acidosis, cerebral involvement, renal impairment, and chronic illness are key independent predictors for a poor outcome in African children with severe malaria. Mortality is markedly increased in cerebral malaria combined with acidosis. Clinical Trial Registration. ISRCTN50258054.
Date Issued
2012-03-12
Date Acceptance
2011-12-06
Citation
Clinical Infectious Diseases, 2012, 54 (8), pp.1080-1090
ISSN
1537-6591
Publisher
Oxford University Press (OUP)
Start Page
1080
End Page
1090
Journal / Book Title
Clinical Infectious Diseases
Volume
54
Issue
8
Copyright Statement
© The Author 2012. Published by Oxford University Press on behalf of the Infectious
Diseases Society of America. All rights reserved. For Permissions, please
email:journals.permissions@oup.com. This is an Open Access article distributed
under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted noncommercial
use, distribution, and reproduction in any medium, provided the original
work is properly cited
Diseases Society of America. All rights reserved. For Permissions, please
email:journals.permissions@oup.com. This is an Open Access article distributed
under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted noncommercial
use, distribution, and reproduction in any medium, provided the original
work is properly cited
Identifier
PII: cis034
Subjects
Africa
Antimalarials
Artemisinins
Child
Child, Preschool
Female
Humans
Infant
Injections, Intravenous
Malaria, Falciparum
Male
Prognosis
Quinine
Severity of Illness Index
Treatment Outcome
Publication Status
Published